A Study Evaluating Systemic Exposure and Pharmacodynamics in Patients With Chronic Obstructive Pulmonary Disease
Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the systemic exposure and pharmacodynamics of two
doses of nebulized fluticasone/formoterol combination as compared to the monocomponents.